"Covalent biosensing" enables a one-step, reagent-less, low-cost and highly robust assay of SARS-CoV-2.

Kai ZhangJinlong LiZhenqiang FanHao LiJing-Juan Xu

Published in: Chemical communications (Cambridge, England) (2021)

We have established a new protocol for detecting severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) using a peptidomimetic to covalently detect a viral marker protease.

Keyphrases

sars cov
low cost
respiratory syndrome coronavirus
randomized controlled trial
high throughput
case report
respiratory tract
label free